Interferon gamma mediates the reduction of adipose tissue regulatory T cells in human obesity

干扰素γ介导人类肥胖症中脂肪组织调节性T细胞的减少。

阅读:5
作者:David Bradley # ,Alan J Smith # ,Alecia Blaszczak ,Dharti Shantaram ,Stephen M Bergin ,Anahita Jalilvand ,Valerie Wright ,Kathleen L Wyne ,Revati S Dewal ,Lisa A Baer ,Katherine R Wright ,Kristin I Stanford ,Bradley Needleman ,Stacy Brethauer ,Sabrena Noria ,David Renton ,Joshua J Joseph ,Amy Lovett-Racke ,Joey Liu ,Willa A Hsueh

Abstract

Decreased adipose tissue regulatory T cells contribute to insulin resistance in obese mice, however, little is known about the mechanisms regulating adipose tissue regulatory T cells numbers in humans. Here we obtain adipose tissue from obese and lean volunteers. Regulatory T cell abundance is lower in obese vs. lean visceral and subcutaneous adipose tissue and associates with reduced insulin sensitivity and altered adipocyte metabolic gene expression. Regulatory T cells numbers decline following high-fat diet induction in lean volunteers. We see alteration in major histocompatibility complex II pathway in adipocytes from obese patients and after high fat ingestion, which increases T helper 1 cell numbers and decreases regulatory T cell differentiation. We also observe increased expression of inhibitory co-receptors including programmed cell death protein 1 and OX40 in visceral adipose tissue regulatory T cells from patients with obesity. In human obesity, these global effects of interferon gamma to reduce regulatory T cells and diminish their function appear to instigate adipose inflammation and suppress adipocyte metabolism, leading to insulin resistance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。